Clinical Trials on MGMT-Unmethylated Glioblastoma in Sweden
Total 21 results
-
Cecilia Soderberg-NauclerKarolinska University Hospital; Karolinska InstitutetRecruitingGlioblastoma MultiformeSweden
-
Sahlgrenska University Hospital, SwedenTerminated
-
Peter SiesjöLund UniversityRecruiting
-
Clinical Laserthermia Systems ABRecruiting
-
Karolinska InstitutetKarolinska University HospitalCompletedGlioblastoma Multiforme | Cytomegalovirus InfectionSweden
-
Karolinska University HospitalPhilips HealthcareCompletedGlioblastoma | Surgical MarginSweden
-
CytoVac A/SCompleted
-
AstraZenecaCompleted
-
Rigshospitalet, DenmarkDanish Center for Interventional Research in Radiation Oncology (CIRRO)Terminated
-
Peter SiesjöLund University; Region Skane; Skane University Hospital; Lantmannen Medical ABCompletedGlioblastoma | Chemotherapy Effect | Cerebral EdemaSweden
-
Sahlgrenska University Hospital, SwedenKarolinska University Hospital; St. Olavs Hospital; University Hospital, Linkoeping and other collaboratorsCompleted
-
St. Olavs HospitalOdense University Hospital; Karolinska University Hospital; Turku University... and other collaboratorsRecruiting
-
NovoCure Ltd.CompletedGlioblastoma MultiformeUnited States, Spain, France, Canada, Korea, Republic of, Austria, Israel, Czech Republic, Germany, Italy, Sweden, Switzerland
-
CelgeneActive, not recruitingGlioblastomaSpain, United States, Denmark, Italy, Netherlands, Norway, Sweden
-
Hoffmann-La RocheCompletedGlioblastomaUnited Kingdom, Austria, Croatia, France, Italy, Spain, Turkey, Romania, Portugal, Canada, Greece, Sweden, Bulgaria, Estonia, Latvia
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, Belgium, Denmark, Korea, Republic of, Poland, Spain, Canada, Sweden, Russian Federation, Australia, Greece, Portugal, France, Netherlands, New Zealand, Switzerland, Germany, Hong Kong, Hungary, Israel and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingBrain NeoplasmsUnited States, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBrain CancerUnited States, Canada, Belgium, Spain, Australia, Netherlands, United Kingdom, Denmark, Norway, Japan, Sweden, France, Poland, Austria, Germany, Israel, Italy, Russian Federation, Switzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Novartis PharmaceuticalsCompletedGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditionsUnited States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Brazil, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel